Low‐Dose Interleukin‐2 for Refractory Autoimmune Hepatitis-Reference-Cited by-同舟云学术

Low‐Dose Interleukin‐2 for Refractory Autoimmune Hepatitis

Published:2018-10 Issue:4 Volume:68 Page:1649-1652
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Lim Tiong Y.¹^ORCID,Martinez‐Llordella Marc¹,Kodela Elisavet¹,Gray Elisabeth¹,Heneghan Michael A.¹,Sanchez‐Fueyo Alberto¹

Affiliation:

1. Institute of Liver Studies, King’s College Hospital, Medical Research Council Centre for Transplantation, School of Immunology & Microbial Sciences, Faculty of Life Sciences and MedicineKing’s College London London UK

Funder

King's Health Partners

Medical Research Council

European Association for the Study of the Liver

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hep.30059

Reference4 articles.

1. Low-Dose Interleukin-2 Therapy Restores Regulatory T Cell Homeostasis in Patients with Chronic Graft-Versus-Host Disease

2. Low-dose interleukin 2 in patients with type 1 diabetes: a phase 1/2 randomised, double-blind, placebo-controlled trial

3. In autoimmune hepatitis type 1 or the autoimmune hepatitis-sclerosing cholangitis variant defective regulatory T-cell responsiveness to IL-2 results in low IL-10 production and impaired suppression

4. Liver inflammation abrogates immunological tolerance induced by Kupffer cells

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessment of SLEDAI score changes in systemic lupus erythematosus patients under low-dose interleukin-2 therapy: A meta-analysis;Clinical Epidemiology and Global Health;2024-09

2. Modulating regulatory T cell migration in the treatment of autoimmunity and autoinflammation;Current Opinion in Pharmacology;2024-08

3. B and T cells: (Still) the dominant orchestrators in autoimmune hepatitis;Autoimmunity Reviews;2024-07

4. Second- and third-line treatment agents in autoimmune hepatitis (AIH): Where do we stand?;Exploration of Digestive Diseases;2024-04-10

5. Immune regulation and therapeutic application of T regulatory cells in liver diseases;Frontiers in Immunology;2024-03-20